PACTR202408837266041CompletedUnknown
The impact of the combination of primaquine and chloroquine on parasite transmission to mosquitoes and clearance in Plasmodium vivax cases in Ethiopia
niversity of Bergen0 sites56 target enrollmentStarted: July 20, 2024Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Completed
- Sponsor
- Enrollment
- 56
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 19 Year(s) to 44 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Patients aged 15 or older
- •Those diagnosed with P. vivax mono-infection by microscopy.
- •Those willing to provide written consent/assent and committed to attending all scheduled visits.
Exclusion Criteria
- •Pregnant and breastfeeding women
- •Individuals with illnesses other than malaria caused by P. vivax mono-infection
- •Those who had taken antimalarial drugs within two weeks before enrollment.
Investigators
Similar Trials
Not yet recruiting
Phase 4
Effect of Primaquine in the patients of P.vivax and P.falciparum malaria.CTRI/2010/091/001040il50
Completed
Phase 4
Pharmacokinetic cross-over study of compounded chenodeoxycholic acidcerebrotendinous xanthomatosisCTX10021605NL-OMON49918Amsterdam UMC12
Active, not recruiting
Phase 1
Pharmacology of pharmacy prepared chenodeoxycholic acid.CTXCTEUCTR2021-003823-14-NLAmsterdam UMC12
Not yet recruiting
Phase 1
Role of efficacy of Chandasava and Drakshasava in Alcohol Deaddiction.CTRI/2023/09/057906ational Institute of Ayurveda
Terminated
Phase 4
Comparative effectiveness of Chloroquine and Vitamin C prophylaxis in household contacts of confirmed COVID-19 patientsHousehold members of newly diagnosed COVID-19 patientsHousehold membersCOVID-19ProphylaxisTCTR20200404004Health Systems Research Institute (HSRI)400